203 related articles for article (PubMed ID: 37311743)
1. Structural insights into Siglec-15 reveal glycosylation dependency for its interaction with T cells through integrin CD11b.
Lenza MP; Egia-Mendikute L; Antoñana-Vildosola A; Soares CO; Coelho H; Corzana F; Bosch A; Manisha P; Quintana JI; Oyenarte I; Unione L; Moure MJ; Azkargorta M; Atxabal U; Sobczak K; Elortza F; Sutherland JD; Barrio R; Marcelo F; Jiménez-Barbero J; Palazon A; Ereño-Orbea J
Nat Commun; 2023 Jun; 14(1):3496. PubMed ID: 37311743
[TBL] [Abstract][Full Text] [Related]
2. Siglec-15 recognition of sialoglycans on tumor cell lines can occur independently of sialyl Tn antigen expression.
Murugesan G; Correia VG; Palma AS; Chai W; Li C; Feizi T; Martin E; Laux B; Franz A; Fuchs K; Weigle B; Crocker PR
Glycobiology; 2021 Jan; 31(1):44-54. PubMed ID: 32501471
[TBL] [Abstract][Full Text] [Related]
3. Structural characterisation of high affinity Siglec-2 (CD22) ligands in complex with whole Burkitt's lymphoma (BL) Daudi cells by NMR spectroscopy.
Madge PD; Maggioni A; Pascolutti M; Amin M; Waespy M; Bellette B; Thomson RJ; Kelm S; von Itzstein M; Haselhorst T
Sci Rep; 2016 Nov; 6():36012. PubMed ID: 27808110
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia.
Cyr MG; Mhibik M; Qi J; Peng H; Chang J; Gaglione EM; Eik D; Herrick J; Venables T; Novick SJ; Courouble VV; Griffin PR; Wiestner A; Rader C
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36442911
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7.
van Houtum EJH; Kers-Rebel ED; Looman MW; Hooijberg E; Büll C; Granado D; Cornelissen LAM; Adema GJ
Cell Mol Life Sci; 2023 May; 80(6):169. PubMed ID: 37253806
[TBL] [Abstract][Full Text] [Related]
6. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins.
Brinkman-Van der Linden EC; Varki A
J Biol Chem; 2000 Mar; 275(12):8625-32. PubMed ID: 10722702
[TBL] [Abstract][Full Text] [Related]
7. CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice.
Brinkman-Van der Linden EC; Angata T; Reynolds SA; Powell LD; Hedrick SM; Varki A
Mol Cell Biol; 2003 Jun; 23(12):4199-206. PubMed ID: 12773563
[TBL] [Abstract][Full Text] [Related]
8. Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells.
Meril S; Harush O; Reboh Y; Matikhina T; Barliya T; Cohen CJ
Mol Carcinog; 2020 Jul; 59(7):713-723. PubMed ID: 32391973
[TBL] [Abstract][Full Text] [Related]
9. Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity.
Huang J; Li M; Mei B; Li J; Zhu Y; Guo Q; Huang J; Zhang G
J Transl Med; 2022 Oct; 20(1):496. PubMed ID: 36316782
[TBL] [Abstract][Full Text] [Related]
10. Mouse Siglec-1 Mediates trans-Infection of Surface-bound Murine Leukemia Virus in a Sialic Acid N-Acyl Side Chain-dependent Manner.
Erikson E; Wratil PR; Frank M; Ambiel I; Pahnke K; Pino M; Azadi P; Izquierdo-Useros N; Martinez-Picado J; Meier C; Schnaar RL; Crocker PR; Reutter W; Keppler OT
J Biol Chem; 2015 Nov; 290(45):27345-27359. PubMed ID: 26370074
[TBL] [Abstract][Full Text] [Related]
11. The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway.
Takamiya R; Ohtsubo K; Takamatsu S; Taniguchi N; Angata T
Glycobiology; 2013 Feb; 23(2):178-87. PubMed ID: 23035012
[TBL] [Abstract][Full Text] [Related]
12. CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function.
Bandala-Sanchez E; G Bediaga N; Goddard-Borger ED; Ngui K; Naselli G; Stone NL; Neale AM; Pearce LA; Wardak A; Czabotar P; Haselhorst T; Maggioni A; Hartley-Tassell LA; Adams TE; Harrison LC
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):7783-7788. PubMed ID: 29997173
[TBL] [Abstract][Full Text] [Related]
13. Structures of the Inhibitory Receptor Siglec-8 in Complex with a High-Affinity Sialoside Analogue and a Therapeutic Antibody.
Lenza MP; Atxabal U; Nycholat C; Oyenarte I; Franconetti A; Quintana JI; Delgado S; Núñez-Franco R; Garnica Marroquín CT; Coelho H; Unione L; Jiménez-Oses G; Marcelo F; Schubert M; Paulson JC; Jiménez-Barbero J; Ereño-Orbea J
JACS Au; 2023 Jan; 3(1):204-215. PubMed ID: 36711084
[TBL] [Abstract][Full Text] [Related]
14. The sialoglycan-Siglec glyco-immune checkpoint - a target for improving innate and adaptive anti-cancer immunity.
Bärenwaldt A; Läubli H
Expert Opin Ther Targets; 2019 Oct; 23(10):839-853. PubMed ID: 31524529
[No Abstract] [Full Text] [Related]
15. Saturation transfer difference NMR and computational modeling of a sialoadhesin-sialyl lactose complex.
Bhunia A; Jayalakshmi V; Benie AJ; Schuster O; Kelm S; Rama Krishna N; Peters T
Carbohydr Res; 2004 Jan; 339(2):259-67. PubMed ID: 14698884
[TBL] [Abstract][Full Text] [Related]
16. Multivalent Interactions of Human Primary Amine Oxidase with the V and C22 Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase Activity.
Elovaara H; Parkash V; Fair-Mäkelä R; Salo-Ahen OM; Guédez G; Bligt-Lindén E; Grönholm J; Jalkanen S; Salminen TA
PLoS One; 2016; 11(11):e0166935. PubMed ID: 27893774
[TBL] [Abstract][Full Text] [Related]
17. Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9.
Miyazaki K; Sakuma K; Kawamura YI; Izawa M; Ohmori K; Mitsuki M; Yamaji T; Hashimoto Y; Suzuki A; Saito Y; Dohi T; Kannagi R
J Immunol; 2012 May; 188(9):4690-700. PubMed ID: 22467657
[TBL] [Abstract][Full Text] [Related]
18. Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b β2-integrin-dependent signaling.
McMillan SJ; Sharma RS; McKenzie EJ; Richards HE; Zhang J; Prescott A; Crocker PR
Blood; 2013 Mar; 121(11):2084-94. PubMed ID: 23315163
[TBL] [Abstract][Full Text] [Related]
19. Early murine T-lymphocyte activation is accompanied by a switch from N-Glycolyl- to N-acetyl-neuraminic acid and generation of ligands for siglec-E.
Redelinghuys P; Antonopoulos A; Liu Y; Campanero-Rhodes MA; McKenzie E; Haslam SM; Dell A; Feizi T; Crocker PR
J Biol Chem; 2011 Oct; 286(40):34522-32. PubMed ID: 21835922
[TBL] [Abstract][Full Text] [Related]
20. Siglec-15/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis.
Wang Y; Xu Z; Wu KL; Yu L; Wang C; Ding H; Gao Y; Sun H; Wu YH; Xia M; Chen Y; Xiao H
Proc Natl Acad Sci U S A; 2024 Jan; 121(5):e2312929121. PubMed ID: 38252825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
